BIRZEIT PHARMACEUTICALS COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.09 USD | 0.00% |
|
0.00% | -6.41% |
| Feb. 25 | Birzeit Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 09 | What does the Gotham City report say about Grifols? | RE |
Financials (USD)
| Sales 2022 | 47.03M | Sales 2023 | 43.13M | Capitalization | 169M |
|---|---|---|---|---|---|
| Net income 2022 | 7M | Net income 2023 | 6M | EV / Sales 2022 | 3.31 x |
| Net cash position 2022 | 15.41M | Net cash position 2023 | 17.19M | EV / Sales 2023 | 3.53 x |
| P/E ratio 2022 |
21.5
x | P/E ratio 2023 |
27.3
x | Employees | - |
| Yield 2022 |
2.27% | Yield 2023 |
-
| Free-Float | 73.92% |
More Fundamentals
* Assessed data
More news
| Current month | -2.39% | ||
| 1 month | -2.39% | ||
| 3 months | -6.41% | ||
| 6 months | -2.62% | ||
| Current year | -6.41% |
1 week
4.09
4.09
1 month
4.004.22
Current year
4.004.25
1 year
3.714.46
3 years
2.534.46
5 years
2.314.46
10 years
1.434.46
| Managers | Title | Age | Since |
|---|---|---|---|
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 84-03-31 |
| Director of Finance/CFO | - | 84-11-14 | |
| Chief Tech/Sci/R&D Officer | - | 97-01-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 20-12-31 | |
| Chief Administrative Officer | 54 | 91-12-31 | |
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 84-03-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 4.09 | 0.00% | 395 |
| 24-04-17 | 4.09 | 0.00% | 519 |
| 24-04-16 | 4.09 | -0.49% | 1,459 |
End-of-day quote Palestine Exchange, April 21, 2024
More quotes
Birzeit Pharmaceutical Company Ltd is a Palestine-based pharmaceutical company engaged in manufacturing and distributing generic medicines products in a variety of therapeutic fields. The Company manufactures and markets more than 300 products distributed among ten lines of production: Ampoules, Capsules, Tablets and Caplets, Syrups, Suspensions and Granules, Ophthalmic, Semi-solids, Powder vials, Suppositories and Powders. In addition to customers in the local Palestinian market, including Ministry of Health, local health care organizations, international health care organizations and programs, the Company has also presence in different export markets, mainly Algeria and East Europe. The Company also operates through its subsidiaries included Palestine Printing and Publishing Company and Midex for Medical Supplies.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -6.41% | 159M | |
| +17.97% | 42.77B | |
| +20.21% | 22.23B | |
| +12.64% | 14.44B | |
| +12.19% | 13.05B | |
| +35.45% | 11.59B | |
| -8.80% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +5.03% | 4.97B |
- Stock Market
- Equities
- BPC Stock
